Compounds > pyrimidin-2-one beta-ribofuranoside
Page last updated: 2024-08-26

pyrimidin-2-one beta-ribofuranoside and Disease Models, Animal

pyrimidin-2-one beta-ribofuranoside has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, RR; Dang, D; Ono, K; Schmidt, BL; Viet, CT; Ye, Y1
Dock, H; Theodorsson, A; Theodorsson, E1
Brown, KD; Chen, M; Dyer, LM; Hochwald, SN; Hollingshead, M; Hunter, KW; Kaye, FJ; Marquez, VE; Nawab, A; Shabashvili, D; Steeg, P; Yang, SX; Zajac-Kaye, M1
Alleman, WG; Aprelikova, ON; Chandramouli, GV; Linehan, WM; Mendoza, A; Rodgers, C; Rogers, C; Sopko, NA; Tabios, RL; Torres-Cabala, C; Vasselli, JR1

Other Studies

4 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Disease Models, Animal

ArticleYear
Demethylating drugs as novel analgesics for cancer pain.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Sep-15, Volume: 20, Issue:18

    Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Cytidine; Decitabine; Disease Models, Animal; DNA Methylation; Heterografts; Humans; Immunohistochemistry; In Situ Hybridization; Mice; Mouth Neoplasms; Neurons; Pain; Receptors, Opioid, mu; Reverse Transcriptase Polymerase Chain Reaction; Transduction, Genetic; Trigeminal Ganglion

2014
DNA Methylation Inhibitor Zebularine Confers Stroke Protection in Ischemic Rats.
    Translational stroke research, 2015, Volume: 6, Issue:4

    Topics: Analysis of Variance; Animals; Brain Infarction; Cytidine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Wistar; Reperfusion

2015
DNA methyltransferase inhibitor, zebularine, delays tumor growth and induces apoptosis in a genetically engineered mouse model of breast cancer.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:2

    Topics: Administration, Oral; Animals; Antigens, Polyomavirus Transforming; Apoptosis; Breast Neoplasms; Cytidine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Necrosis; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden

2012
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Oct-15, Volume: 10, Issue:20

    Topics: Adenocarcinoma, Clear Cell; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cytidine; Decitabine; Disease Models, Animal; DNA Methylation; Gene Silencing; Humans; Kidney Neoplasms; Mice; Pyrimidine Nucleosides; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein

2004